Arcadia Biosciences Inc.

2.93
-0.04 (-1.35%)
At close: Apr 01, 2025, 3:50 PM
3.16
7.89%
Pre-market: Apr 02, 2025, 05:02 AM EDT

Arcadia Biosciences Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018
Product Revenue 1.54M 1.31M 1.25M 1.38M 1.51M 993K 1.85M 2.95M 3.17M 2.08M 2.32M 1.38M 803K 414K 245K 231K 154K 329K 216K 162K 107K 144K 188K
Product Revenue Growth +17.69% +4.06% -8.99% -8.61% +51.96% -46.35% -37.17% -7.07% +52.33% -10.46% +68.53% +71.73% +93.96% +68.98% +6.06% +50.00% -53.19% +52.31% +33.33% +51.40% -25.69% -23.40% n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Argentina Revenue 862K 26K 6.68M 258K 91K 1.06M 202K
Argentina Revenue Growth +3215.38% -99.61% +2489.53% +183.52% -91.45% +426.73% n/a
Canada Revenue 194K 503K 354K 7K 90K 181K 2.71M
Canada Revenue Growth -61.43% +42.09% +4957.14% -92.22% -50.28% -93.33% n/a
Germany Revenue 57K 7K 100K 722K 1.17M 1.59M n/a
Germany Revenue Growth +714.29% -93.00% -86.15% -38.18% -26.45% n/a n/a
India Revenue 7K 6M 761K n/a n/a n/a n/a
India Revenue Growth -99.88% +688.83% n/a n/a n/a n/a n/a
United States Revenue 8.84M n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 2.24M 2.68M 3.19M 3.42M 3.44M 3.81M 4.39M 4.21M 4.83M 4.65M 4.35M 6.19M 6.31M 6.37M 4.07M 4.78M 4.29M 3.67M 3.72M 3.13M 4.48M 3.15M 2.81M 3.02M 3.01M 2.95M 2.62M 2.24M 2.42M 2.94M 3.05M 3.37M 2.69M 2.76M 3.44M 2.88M 2.82M 2.79M 2.64M
Selling, General, and Administrative Revenue Growth -16.47% -15.87% -6.84% -0.58% -9.75% -13.14% +4.22% -12.84% +3.93% +6.97% -29.72% -1.96% -0.91% +56.55% -14.84% +11.32% +16.82% -1.32% +18.83% -30.02% +42.35% +11.84% -6.98% +0.40% +2.10% +12.51% +16.96% -7.20% -17.94% -3.57% -9.38% +25.34% -2.61% -19.70% +19.39% +2.13% +1.18% +5.57% n/a
Research and Development Revenue 24K 10K 272K 332K 305K 391K 359K 500K 255K 359K 395K 561K 1.04M 1.13M 1.16M 1.96M 1.76M 1.99M 2.24M 1.71M 1.93M 1.95M 1.5M 1.54M 1.33M 1.79M 1.4M 2.17M 1.75M 1.67M 1.82M 1.99M 2.25M 2.22M 2.2M 1.87M 3.18M 2.09M 1.83M
Research and Development Revenue Growth +140.00% -96.32% -18.07% +8.85% -21.99% +8.91% -28.20% +96.08% -28.97% -9.11% -29.59% -45.95% -8.22% -2.42% -40.90% +11.29% -11.59% -11.19% +31.15% -11.39% -0.97% +29.57% -2.59% +15.82% -25.64% +28.51% -35.55% +23.84% +4.79% -8.45% -8.39% -11.75% +1.76% +0.64% +17.82% -41.21% +52.40% +13.86% n/a